logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 3
  • 1
    Beresford, Sasha
    Director born in October 1970
    Individual (2 offsprings)
    Officer
    2012-01-13 ~ now
    OF - Director → CIF 0
  • 2
    Rupert Graham Mullins
    Individual (127 offsprings)
    Insolvency
    2016-02-26 ~ now
    IP - (Case 1) practitioner → CIF 0
  • 3
    Beresford, Mark, Dr
    Director born in April 1971
    Individual (1 offspring)
    Officer
    2012-01-13 ~ now
    OF - Director → CIF 0
parent relation
Company in focus

BERESFORD ONCOLOGY LIMITED

Period: 2012-01-13 ~ 2017-03-30
Company number: 07909290
Registered name
BERESFORD ONCOLOGY LIMITED - Dissolved
Standard Industrial Classification
86220 - Specialists Medical Practice Activities
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Tangible fixed assets
355 GBP2015-01-31
Debtors
4,937 GBP2016-02-25
14,238 GBP2015-01-31
Cash at bank and in hand
130,826 GBP2016-02-25
104,324 GBP2015-01-31
Current Assets
135,763 GBP2016-02-25
118,562 GBP2015-01-31
Current liabilities
-31,114 GBP2016-02-25
-22,923 GBP2015-01-31
Net Current Assets/Liabilities
104,649 GBP2016-02-25
95,639 GBP2015-01-31
Net assets/liabilities including pension asset/liability
104,649 GBP2016-02-25
95,994 GBP2015-01-31
Called-up share capital
2 GBP2016-02-25
2 GBP2015-01-31
Retained earnings
104,647 GBP2016-02-25
95,992 GBP2015-01-31
Capital employed
104,649 GBP2016-02-25
95,994 GBP2015-01-31
Cost/valuation of tangible fixed assets
632 GBP2015-01-31
Tangible fixed assets - Disposals
-632 GBP2015-02-01 ~ 2016-02-25
Depreciation of tangible fixed assets
277 GBP2015-01-31
Tangible fixed assets - Decrease/increase in depreciation due to disposals
-277 GBP2015-02-01 ~ 2016-02-25
Par Value of Share
Class 1 ordinary share
1 GBP2015-02-01 ~ 2016-02-25
Number of shares allotted
Class 1 ordinary share
2 shares2016-02-25
Paid-up share capital
Class 1 ordinary share
2 GBP2016-02-25
2 GBP2015-01-31

  • BERESFORD ONCOLOGY LIMITED
    Info
    Registered number 07909290
    Citypoint, Temple Gate, Bristol, Bristol BS1 6PL
    PRIVATE LIMITED COMPANY incorporated on 2012-01-13 and dissolved on 2017-03-30 (5 years 2 months). The status of the company number is Dissolved.
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.